Allogene Therapeutics (ALLO) null Earnings

4NovConfirmed
Feb 20
May 20
Aug 20
Nov 20
-0.68
-0.62
-0.56
-0.5

Details

Expected EPS
-0.54
Actual EPS
-0.52
Surprise EPS
0.02
Surprise Percent
+3.7%

Description

Allogene Therapeutics (ALLO) has reported earnings of -0.52 per share for .

0 Comments

Share your thoughts